Status:
TERMINATED
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
Lead Sponsor:
SWOG Cancer Research Network
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
55-120 years
Brief Summary
RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care. PURPOSE: Thi...
Detailed Description
OBJECTIVES: * Compare the time to metastases in patients who were diagnosed with high grade or low grade prostate cancer on or before December 31, 2003 and were treated with finasteride or placebo wh...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Randomized on PCPT
- Diagnosed with prostate cancer on or before December 31, 2003
- DISEASE CHARACTERISTICS:
- Diagnosed by either study site or central pathology review
- PATIENT CHARACTERISTICS:
- See inclusion criteria
- PRIOR CONCURRENT THERAPY:
- Not Applicable
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
961 Patients enrolled
Trial Details
Trial ID
NCT00288106
Start Date
September 1 2005
End Date
May 1 2009
Last Update
September 30 2015
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States, 33308
2
Ella Milbank Foshay Cancer Center at Jupiter Medical Center
Jupiter, Florida, United States, 33458
3
CCOP - Mount Sinai Medical Center
Miami Beach, Florida, United States, 33140
4
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States, 62526